This chapter applies to all maximum allowable cost pricing claims made to a pharmacy benefits manager for a multisource generic prescription drug, medical product, or device, provided to a beneficiary of a purchaser.

Authority: Insurance Article, §§15-1601, 15-1604, 15-1605, 15-1607, 15-1609, 15-1628, 15-1628.1, and 15-1642, Annotated Code of Maryland

Effective date: Effective March 23, 2020 (47:6 Md. R. 343)

Regulation .02B amended effective February 7, 2022 (49:3 Md. R. 141)

Regulation .03 amended effective February 7, 2022 (49:3 Md. R. 141)